Cargando…
Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients
BACKGROUND: Peutz-Jeghers syndrome (PJS) is an autosomal dominant genetic disease with skin mucosal pigment spots and gastrointestinal (GI) multiple hamartoma polyps as clinical characteristics. At present, it is considered that the germline mutation of STK11 gene is the genetic cause of PJS. Howeve...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292148/ https://www.ncbi.nlm.nih.gov/pubmed/37377590 http://dx.doi.org/10.3748/wjg.v29.i21.3302 |
_version_ | 1785062826937679872 |
---|---|
author | Jiang, Li-Xin Chen, Yu-Rui Xu, Zu-Xin Zhang, Yu-Hui Zhang, Zhi Yu, Peng-Fei Dong, Zhi-Wei Yang, Hai-Rui Gu, Guo-Li |
author_facet | Jiang, Li-Xin Chen, Yu-Rui Xu, Zu-Xin Zhang, Yu-Hui Zhang, Zhi Yu, Peng-Fei Dong, Zhi-Wei Yang, Hai-Rui Gu, Guo-Li |
author_sort | Jiang, Li-Xin |
collection | PubMed |
description | BACKGROUND: Peutz-Jeghers syndrome (PJS) is an autosomal dominant genetic disease with skin mucosal pigment spots and gastrointestinal (GI) multiple hamartoma polyps as clinical characteristics. At present, it is considered that the germline mutation of STK11 gene is the genetic cause of PJS. However, not all PJS patients can be detected STK11 germline mutations. The specific clinical characteristics of these PJS patients without STK11 mutation is an interesting clinical question. Or, like wild type GI stromal tumor, whether these PJS without STK11 mutation are also called PJS is worth discussing. Therefore, we designed the study to understand the clinical characteristics of these PJS patients without STK11 mutation. AIM: To investigates whether PJS patients with known STK11 mutations have a more severe spectrum of clinical phenotypes compared to those without. METHODS: A total of 92 patients with PJS admitted to the Air Force Medical Center from 2010 to 2022 were randomly selected for study. Genomic DNA samples were extracted from peripheral blood samples, and pathogenic germline mutations of STK11 were detected by high-throughput next-generation gene sequencing. Clinical-pathologic manifestations of patients with and without STK11/LKB1 mutations were compared. RESULTS: STK11 germline mutations were observed in 73 patients with PJS. Among 19 patients with no detectable STK11 mutations, six had no pathogenic germline mutations of other genes, while 13 had other genetic mutations. Compared with PJS patients with STK11 mutations, those without tended to be older at the age of initial treatment, age of first intussusception and age of initial surgery. They also had a lower number of total hospitalizations relating to intussusception or intestinal obstruction, and a lower load of small intestine polyps. CONCLUSION: PJS patients without STK11 mutations might have less severe clinical-pathologic manifestations than those with. |
format | Online Article Text |
id | pubmed-10292148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-102921482023-06-27 Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients Jiang, Li-Xin Chen, Yu-Rui Xu, Zu-Xin Zhang, Yu-Hui Zhang, Zhi Yu, Peng-Fei Dong, Zhi-Wei Yang, Hai-Rui Gu, Guo-Li World J Gastroenterol Clinical Trials Study BACKGROUND: Peutz-Jeghers syndrome (PJS) is an autosomal dominant genetic disease with skin mucosal pigment spots and gastrointestinal (GI) multiple hamartoma polyps as clinical characteristics. At present, it is considered that the germline mutation of STK11 gene is the genetic cause of PJS. However, not all PJS patients can be detected STK11 germline mutations. The specific clinical characteristics of these PJS patients without STK11 mutation is an interesting clinical question. Or, like wild type GI stromal tumor, whether these PJS without STK11 mutation are also called PJS is worth discussing. Therefore, we designed the study to understand the clinical characteristics of these PJS patients without STK11 mutation. AIM: To investigates whether PJS patients with known STK11 mutations have a more severe spectrum of clinical phenotypes compared to those without. METHODS: A total of 92 patients with PJS admitted to the Air Force Medical Center from 2010 to 2022 were randomly selected for study. Genomic DNA samples were extracted from peripheral blood samples, and pathogenic germline mutations of STK11 were detected by high-throughput next-generation gene sequencing. Clinical-pathologic manifestations of patients with and without STK11/LKB1 mutations were compared. RESULTS: STK11 germline mutations were observed in 73 patients with PJS. Among 19 patients with no detectable STK11 mutations, six had no pathogenic germline mutations of other genes, while 13 had other genetic mutations. Compared with PJS patients with STK11 mutations, those without tended to be older at the age of initial treatment, age of first intussusception and age of initial surgery. They also had a lower number of total hospitalizations relating to intussusception or intestinal obstruction, and a lower load of small intestine polyps. CONCLUSION: PJS patients without STK11 mutations might have less severe clinical-pathologic manifestations than those with. Baishideng Publishing Group Inc 2023-06-07 2023-06-07 /pmc/articles/PMC10292148/ /pubmed/37377590 http://dx.doi.org/10.3748/wjg.v29.i21.3302 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Clinical Trials Study Jiang, Li-Xin Chen, Yu-Rui Xu, Zu-Xin Zhang, Yu-Hui Zhang, Zhi Yu, Peng-Fei Dong, Zhi-Wei Yang, Hai-Rui Gu, Guo-Li Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients |
title | Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients |
title_full | Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients |
title_fullStr | Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients |
title_full_unstemmed | Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients |
title_short | Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients |
title_sort | peutz-jeghers syndrome without stk11 mutation may correlate with less severe clinical manifestations in chinese patients |
topic | Clinical Trials Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292148/ https://www.ncbi.nlm.nih.gov/pubmed/37377590 http://dx.doi.org/10.3748/wjg.v29.i21.3302 |
work_keys_str_mv | AT jianglixin peutzjegherssyndromewithoutstk11mutationmaycorrelatewithlesssevereclinicalmanifestationsinchinesepatients AT chenyurui peutzjegherssyndromewithoutstk11mutationmaycorrelatewithlesssevereclinicalmanifestationsinchinesepatients AT xuzuxin peutzjegherssyndromewithoutstk11mutationmaycorrelatewithlesssevereclinicalmanifestationsinchinesepatients AT zhangyuhui peutzjegherssyndromewithoutstk11mutationmaycorrelatewithlesssevereclinicalmanifestationsinchinesepatients AT zhangzhi peutzjegherssyndromewithoutstk11mutationmaycorrelatewithlesssevereclinicalmanifestationsinchinesepatients AT yupengfei peutzjegherssyndromewithoutstk11mutationmaycorrelatewithlesssevereclinicalmanifestationsinchinesepatients AT dongzhiwei peutzjegherssyndromewithoutstk11mutationmaycorrelatewithlesssevereclinicalmanifestationsinchinesepatients AT yanghairui peutzjegherssyndromewithoutstk11mutationmaycorrelatewithlesssevereclinicalmanifestationsinchinesepatients AT guguoli peutzjegherssyndromewithoutstk11mutationmaycorrelatewithlesssevereclinicalmanifestationsinchinesepatients |